Reference
FDA requires strong warnings for opioid analgesics, prescription opioid cough products, and benzodiazepine labeling related to serious risks and death from combined use. Internet Document : 31 Aug 2016. Available from: URL: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm518697.htm
Rights and permissions
About this article
Cite this article
Risk with combination of opioids and benzodiazepines. Reactions Weekly 1618, 6 (2016). https://doi.org/10.1007/s40278-016-21011-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-21011-4